Acurx Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ACXP Nasdaq 2830 www.acurxpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Acurx Pharmaceuticals, Inc.

Loss-Making Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Expected To Breakeven In The Medium-Term - Jan 21st, 2026 5:28 am
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year? - Jan 6th, 2026 7:40 am
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP) - Dec 20th, 2025 4:15 pm
New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST - Nov 22nd, 2025 9:20 am
Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals - Nov 18th, 2025 6:00 am
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television - Nov 15th, 2025 10:10 am
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update - Nov 12th, 2025 5:01 am
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens - Nov 10th, 2025 6:00 am
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference - Oct 28th, 2025 6:00 am
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update - Oct 27th, 2025 6:00 am
New to The Street to Broadcast Nationwide on Bloomberg TV Tonight at 6:30 PM EST Featuring Roadzen, Spartan Equipment, XION, Metaterra, and YY Group - Oct 25th, 2025 10:55 am
New to The Street Show #694 to Broadcast Tonight at 6:30 PM EST as Sponsored Programming on Bloomberg TV Featuring Stardust Power (NASDAQ:SDST), Spartan Equipment, Roadzen (NASDAQ:RDZN), Aeries Technology (NASDAQ:AERT), and XION - Oct 18th, 2025 11:45 am
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Oct 11th, 2025 10:55 am
Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC - Oct 10th, 2025 1:35 pm
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - Oct 9th, 2025 5:30 am
New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology - Oct 6th, 2025 9:51 pm
New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST - Oct 4th, 2025 11:10 am
Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection - Sep 30th, 2025 5:30 am
New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies - Sep 26th, 2025 4:00 pm
New to The Street to Broadcast Episode 686 Tonight on Bloomberg Television at 6:30 PM EST - Sep 13th, 2025 10:00 am